February 13, 2018 / 12:43 PM / 3 months ago

BRIEF-Ipsen Biopharmaceuticals Canada Says Health Canada Approved Somatuline Autogel For Treatment Of Carcinoid Syndrome

Feb 13 (Reuters) - Ipsen Sa:

* IPSEN BIOPHARMACEUTICALS CANADA SAYS HEALTH CANADA APPROVES SOMATULINE AUTOGEL (LANREOTIDE INJECTION) 120 MG FOR TREATMENT OF CARCINOID SYNDROME Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below